Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15121408.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Adult bone-marrow-derived mesenchymal stem cells are immunosuppressive and prolong the rejection of mismatched skin grafts in animals. We transplanted haploidentical mesenchymal stem cells in a patient with severe treatment-resistant grade IV acute graft-versus-host disease of the gut and liver. Clinical response was striking. The patient is now well after 1 year. We postulate that mesenchymal stem cells have a potent immunosuppressive effect in vivo.
Medical subject headings
- Graft vs Host Disease
- Mesenchymal Stem Cell Transplantation